Displaying items by tag: division of hematology and oncology

Some 70 percent of patients needing a marrow transplant do not have a fully matched donor in their family.
A UAB researcher has received a 2017 Susan G. Komen grant to investigate combination drug therapies for HER2-positive breast cancer.
Research from UAB suggests that nearly half of children with the most common type of leukemia or their parents say they took more medications than they actually did.
A key Leukemia & Lymphoma Society grant will provide an opportunity for a UAB researcher to develop a new immunotherapy treatment approach for the leukemia most prevalent in Western countries.
An Alabama woman asked her primary care physician one question that may have saved her life — is it time for me to have a mammogram?
A fight with breast cancer has brought Odenville Elementary teachers Meg Lowry and Michelle Simmons closer as they learn the disease is “not your grandmother’s story anymore.”
Almost 100 people have signed up for the annual Komen Race for the Cure in honor of Physical Medicine and Rehabilitation’s Yvonne Akins, a mentor and friend to many at UAB for 42 years.
Measure of Mpl gene expression reveals a heterogonous population of leukemia stem cells: one group leukemic and the other group non-leukemic.
The Nov. 10 workshop will provide information and resources for lung cancer patients.
The UAB Comprehensive Cancer Center ranked as one of 100 Hospitals and Health Systems with great oncology programs in America.
UAB researcher reports that brentuximab vedotin may be effective therapy for older patients with Hodgkin Lymphoma who cannot tolerate standard therapy.
Page 4 of 6